stockrowPulmonx Corporation (LUNG) vs Quanterix Corporation (QTRX)
- Pulmonx Corporation LUNG 2.60 +1.56%
- Quanterix Corporation QTRX 2.81 +1.81%
Pulmonx Corporation and Quanterix Corporation are both Medical Devices companies. Quanterix Corporation is the larger, with a market value of $130.5M against $111.5M — 1.2× the size. Quanterix Corporation grew revenue faster over the last twelve months: 22.0% against −3.15%. Pulmonx Corporation has the higher net margin (−47.9% vs −80.3%) and the lower return on invested capital (−129.9% vs −66.5%). Across the 18 metrics below, Pulmonx Corporation leads on 11 and Quanterix Corporation on 7.
Valuation
Profitability
| Metric | LUNG | QTRX | Medical Devices median |
|---|---|---|---|
| Gross margin | 77.42% | 44.56% | 57.76% |
| Operating margin | (44.39%) | (99.65%) | (15.07%) |
| Net margin | (47.93%) | (80.25%) | (14.45%) |
| Free cash flow margin | (28.85%) | (53.24%) | (3.88%) |
| Return on equity | (90.31%) | (46.48%) | (10.35%) |
| Return on assets | (34.25%) | (35.41%) | (17.26%) |
| Return on invested capital | (129.86%) | (66.50%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack